Reynders McVeigh Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,903
| Closed | -$595K | – | 210 |
|
|
2024
Q3 | $595K | Sell |
8,903
-4,767
| -35% | -$319K | 0.03% | 134 |
|
|
2024
Q2 | $1.62M | Buy |
13,670
+618
| +5% | +$73.4K | 0.09% | 80 |
|
|
2024
Q1 | $1.39M | Sell |
13,052
-911
| -7% | -$97.1K | 0.08% | 81 |
|
|
2023
Q4 | $1.39M | Buy |
13,963
+3,588
| +35% | +$357K | 0.09% | 83 |
|
|
2023
Q3 | $1.07M | Sell |
10,375
-1,786
| -15% | -$185K | 0.07% | 89 |
|
|
2023
Q2 | $1.48M | Sell |
12,161
-1,807
| -13% | -$220K | 0.1% | 82 |
|
|
2023
Q1 | $2.15M | Sell |
13,968
-1,000
| -7% | -$154K | 0.15% | 66 |
|
|
2022
Q4 | $2.69M | Sell |
14,968
-1,792
| -11% | -$322K | 0.2% | 65 |
|
|
2022
Q3 | $1.98M | Buy |
16,760
+2,311
| +16% | +$273K | 0.15% | 67 |
|
|
2022
Q2 | $2.06M | Buy |
14,449
+351
| +2% | +$50.1K | 0.15% | 66 |
|
|
2022
Q1 | $2.43M | Buy |
14,098
+9,258
| +191% | +$1.6M | 0.15% | 65 |
|
|
2021
Q4 | $1.23M | Buy |
+4,840
| New | +$1.23M | 0.07% | 100 |
|